With a vaccine now approved in the UK, other countries won’t be far behind. But a vaccine won’t singlehandedly ensure the virus doesn’t cross international borders when travel picks up.
It turns out, if your crisps are sufficiently ‘niche’ and sophisticated, even they can be classed as a meal.
Tony Potts, a 69-year-old retiree, removes his face mask for a temperature check just before receiving his first injection in a phase 3 COVID-19 vaccine clinical trial sponsored by Moderna. Potts is one of 30,000 participants in the Moderna trial.
Paul Hennessy/NurPhoto via Getty ImageS
The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?
A little bit of post-injection soreness is completely normal.
Jose Luis Pelaez Inc/DigitalVision via Getty Images
The side effects of new SARS-CoV-2 vaccines are a result of immune system activation. While uncomfortable, they are both normal and expected. They are a sign that the vaccine is working.
A substantial proportion of people may refuse or delay taking a COVID-19 vaccine.
Shutterstock
Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
A man sips a drink while sitting in environmentally friendly physical distancing circle at Trinity Bellwoods Park in Toronto on May 28, 2020.
THE CANADIAN PRESS/Nathan Denette
As the pandemic wears on, some people struggle to keep adhering to restrictions and social distancing guidelines. There are psychological reasons for caution fatigue, and ways to overcome it.
This is what it’s like fighting COVID-19 the second time around.
A nurse prepares a shot for a clinical trial of a COVID-19 vaccine candidate developed by the National Institutes of Health and Moderna Inc., on July 27, 2020 in Binghamton, N.Y.
(AP Photo/Hans Pennink, File)
With COVID-19 vaccine announcements making headlines, non-scientists need to know what clinical trial results mean. Here are some key points to look for in vaccine trial reports.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne